Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-08

Clinical Trial Update: Detecting Mild Autonomous Cortisol Secretion in Patients With Adrenal Incidentaloma

View source ↗

Summary

The Cleveland Clinic-sponsored trial aims to detect mild autonomous cortisol secretion in patients with adrenal incidentalomas and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The Cleveland Clinic | Conditions: Mild Autonomous Cortisol Secretion (MACS) | Status: RECRUITING